Natural rubber latex allergy is rec...

Natural rubber latex allergy is recognized as an important public health issue and continues to be addressed in one as well as the other the public and private sectors between the sides of rule making, educational efforts, and research. (1) Coincident with the increased recognition of glove reactions in the late 1980 and clinical natural rubber latex allergy in the early 1990 the US cheer and Drug Administration (FDA) began to receive reports describing various health events such as contact dermatitis and allergic reactions, that were associated by the agency of the reporters with the use of medical glove (2) The limit medical glove, from the FDA's regulatory perspective, belongs to a wide variety of glove produces with specific barrier claims that are labeled and marketed for medical use as either surgeon's glove or patient examination glove (3) commonly medical gloves are required to receive FDA premarket clearance below section 510(k) of the meat Drug, and Cosmetic Act before they can be marketed legally in the United States. They also are make submissive to mandatory reporting requirements outlined below the FDA's Medical Device Reporting (MDR) regulations. (4) Glove that are not labeled for medical use, similar as cleaning gloves, painter's glove and wooden horse gloves, are not covered below the FDA's jurisdiction. The FDA's reporting theory does not capture problems directly associated with the use of consumer glove proceedss The aim of this inquiry was to provide a descriptive analysis and summary of health results reported to the FDA in association with the use of medical glove made from either natural rubber latex formulations or synthetic materials.

THE FDA'S REPORTING SYSTEM

Since 1973 the FDA has maintained a nationwide voluntary reporting program for adverse affairs associated with medical devices. generally administered as part of the FDA's MedWatch program, the program accepts information voluntarily submitted to the FDA on health care providers and consumer Beginning in 1984 the FDA's MDR regulations require device manufacturers and importers to submit reports to the FDA concerning medical device-related deaths, serious injuries, and device malfunctions. Since 1991 facilities that use medical devices also have been required to report device-related deaths and serious injuries to either the manufacturer or the FDA. Facilities that use medical devices control to mandatory reporting include hospitals, nursing abodes outpatient diagnostic and treatment facilities, ambulatory surgery center ambulance services, and abode health care service providers. Private offices of physicians, dentists, or other health care professionals are exempted from the FDA's mandatory reporting requirements, unless practitioners can report problems voluntarily to the FDA. From 1990 to 1996 medical device distributors also were required to report certain models of events. Both the mandatory and voluntary reporting combination of parts to form a wholes continue to capture information about medical device-related adverse conclusions and the FDA's adverse occurrence databases currently contain more than the same million reports. The FDA uses the information reported within these programs to assist in the early identification and characterization of emerging medical device puzzles and related public health issues.

METHODS

The FDA's medical device adverse marked occurrence databases were searched via computer using paragraph search criteria (eg, red, rash, allergic, anaphylaxis, asthma, wheezing, reaction, swollen swell, itch, passed out) perform the operations indicated ined to identify reports describing local or systemic reactions associated with the use of any representation of medical glove. The search sheltered information submitted from the inception of the database in 1973 [i]or[/i] part of to the other March 31, 1999. Duplicate reports describing the same end were identified and merged into a single adverse fact report, yielding a total of 2639 candidate reports. A secondary manual review of the candidate reports be the effected in the identification of a subset of 2396 unique reports of glove-associated reactions that serv as the subdue of the study.

Certain prescribed information (eg patient age, sex location of event) must be included in mandatory adverse consequence reports submitted to the FDA unles it cannot be obtained by dint of the reporter. Since 1993, voluntary reporters have been asked to serve instead of basic data elements as part of a standard adverse conclusion report format developed by the FDA, nevertheless voluntary reports are accepted regardless of whether the minimal supplicationed information is provided by the reporter. Narrative information is petitioned for all adverse event reports; however, the FDA's adverse occurrence databases are not designed to capture and collection of laws detailed clinical information associated with an individual device-related circumstance and there are no specific satisfy requirements for the narrative sections of the report form. When supplied, the quality of narrative information varies substantially between reports.

This subject of attention required the use of a secondary database and the unfolding of a unique coding scheme that allowed for manual abstraction and organization of the codfished narrative and information of interest. The coding a whole entailed the creation of dichotomous and nominal variables to portray by action the information of interest in the reports for ingress into the secondary database. The computerized database was created with checks to assume the correct avenue of values for the variables. The manual abstraction was intended to identify, categorize, and record demographic and clinical information contained in the selecteded reports, particularly when such information was provided exclusively in the narrative sections of a report. Clinical information included symptoms, physical findings, or diagnostic metes that were reported in association with a specific glove reaction. This information then was used to assign each report to undivided or more of the following clinical answer categories: